Telemetry Investments, L.L.C. Affimed N.V. Transaction History

Telemetry Investments, L.L.C.

$63.3 Million
Q4 2022

A detailed history of Telemetry Investments, L.L.C. transactions in Affimed N.V. stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 200,000 shares of AFMD stock, worth $750,000. This represents 0.39% of its overall portfolio holdings.

Number of Shares

200,000

Previous 193,500 3.36%

Holding current value

$750,000

Previous $399,000 37.84%

% of portfolio

0.39%

Previous 0.51%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.1 - $2.45 $7,150 - $15,925	6,500 Added 3.36%	200,000 $248,000
Q3 2022 Nov 17, 2022	BUY	$1.96 - $3.32 $6,860 - $11,620	3,500 Added 1.84%	193,500 $399,000
Q2 2022 Aug 15, 2022	BUY	$2.27 - $4.86 $113,500 - $243,000	50,000 Added 35.71%	190,000 $526,000
Q1 2022 May 16, 2022	SELL	$3.69 - $5.65 $37,859 - $57,969	-10,260 Reduced 6.83%	140,000 $612,000
Q4 2021 Feb 14, 2022	BUY	$5.37 - $7.07 $103,329 - $136,040	19,242 Added 14.69%	150,260 $829,000
Q3 2021 Nov 15, 2021	BUY	$5.54 - $7.51 $232,181 - $314,744	41,910 Added 47.03%	131,018 $810,000
Q2 2021 Aug 16, 2021	SELL	$7.78 - $11.4 $57,144 - $83,733	-7,345 Reduced 7.62%	89,108 $757,000
Q1 2021 May 17, 2021	SELL	$5.12 - $8.48 $313,344 - $518,976	-61,200 Reduced 38.82%	96,453 $763,000
Q4 2020 Feb 16, 2021	SELL	$3.16 - $7.03 $356,454 - $792,998	-112,802 Reduced 41.71%	157,653 $918,000
Q3 2020 Nov 16, 2020	BUY	$3.26 - $4.73 $134,263 - $194,805	41,185 Added 17.96%	270,455 $917,000
Q2 2020 Aug 14, 2020	SELL	$1.58 - $4.63 $149,310 - $437,535	-94,500 Reduced 29.19%	229,270 $1.06 Million
Q1 2020 May 15, 2020	SELL	$1.44 - $3.02 $147,339 - $309,003	-102,319 Reduced 24.01%	323,770 $512,000
Q4 2019 Feb 14, 2020	BUY	$2.25 - $3.07 $327,197 - $446,442	145,421 Added 51.81%	426,089 $1.17 Million
Q3 2019 Nov 14, 2019	SELL	$2.67 - $3.65 $1.08 Million - $1.47 Million	-403,371 Reduced 58.97%	280,668 $825,000
Q2 2019 Aug 14, 2019	BUY	$2.6 - $4.21 $855,501 - $1.39 Million	329,039 Added 92.69%	684,039 $1.96 Million
Q1 2019 May 15, 2019	SELL	$3.05 - $4.34 $214,713 - $305,527	-70,398 Reduced 16.55%	355,000 $1.49 Million
Q4 2018 Feb 14, 2019	BUY	$2.82 - $4.67 $673,187 - $1.11 Million	238,719 Added 127.88%	425,398 $1.32 Million
Q3 2018 Nov 14, 2018	SELL	$1.45 - $6.15 $385,665 - $1.64 Million	-265,976 Reduced 58.76%	186,679 $812,000
Q2 2018 Aug 14, 2018	SELL	$1.65 - $2.5 $152,369 - $230,862	-92,345 Reduced 16.94%	452,655 $747,000
Q1 2018 May 15, 2018	SELL	$1.25 - $2.65 $30,967 - $65,651	-24,774 Reduced 4.35%	545,000 $1.01 Million
Q4 2017 Feb 14, 2018	BUY	$1.23 - $2.3 $315,955 - $590,810	256,874 Added 82.09%	569,774 $741,000
Q3 2017 Nov 14, 2017	BUY	$1.95 - $2.25 $610,155 - $704,025	312,900	312,900 $704,000

Others Institutions Holding AFMD

# of Institutions

Shares Held

1.09M

Call Options Held

Put Options Held

View Full List

About Affimed N.V.

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $560M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

More about AFMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.

Account

Telemetry Investments, L.L.C. Affimed N.V. Transaction History